Amphastar Pharmaceuticals(AMPH)
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Amphadase | Hyaluronidase | 2004-10-26 | ||
| Cortrosyn | Cosyntropin | 1982-01-01 | — | |
| Duocaine | Bupivacaine, Lidocaine | 2003-05-23 | 2025-2041 | |
| Enoxaparin | Enoxaparin | 2011-09-19 | ||
| Ganirelix | Ganirelix | 2022-04-07 | ||
| Glucagon | Glucagon | 2020-12-28 | 2036-2039 | |
| Isoproterenol | Isoproterenol | 2018-06-18 | ||
| Ketorolac tromethamine | Ketorolac tromethamine | 2004-07-21 | — | |
| Medroxyprogesterone | Medroxyprogesterone | 2017-11-28 | ||
| Neostigmine methylsulfate | Neostigmine methylsulfate | 2017-09-25 | 2038 | |
| Nitroprusside | Nitroprusside | 2017-12-18 | — | |
| Succinylcholine | Succinylcholine | 2020-06-08 | — | |
| Vasopressin | Vasopressin | 2022-07-18 | 2035 | — |
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use